Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456

NCT03282851 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

696

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MSB11456
DRUG: US-licensed Actemra
DRUG: EU-approved RoActemra

Sponsor

Fresenius Kabi SwissBioSim GmbH